Toggle navigation
Home
Search
Services
Blog
Contact
About
Screening for Neurotoxity of New Treatment Drugs
Moliver, Mark
Johns Hopkins University, Baltimore, MD, United States
Search grants from Mark Moliver
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Native Garden's Project: an Indigeneous Permaculture Approach to the Prevention
Tuberculosis Elimination and Laboratory Cooperative Agreements
Research Administration
Public Health Traineeship
Small Instrumentation Grant
Recently added grants:
PGI2 augments Treg function
Role of T cell-derived amphiregulin in recovery from influenza virus infection
Genital Chlamydia spreading to the gastrointestinal tract promotes chlamydial pathogenicity in the upper genital tract
snoRNA31 is critical for human cell-intrinsic immunity to HSV-1 in the central nervous system
Measuring Chronic Pain Impact
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
N01DA007408-002
Application #
3635442
Study Section
Project Start
1989-09-29
Project End
1993-06-28
Budget Start
1990-06-29
Budget End
1993-06-28
Support Year
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 1991
N01 DA
Screening for Neurotoxity of New Treatment Drugs
Moliver, Mark / Johns Hopkins University
NIH 1989
N01 DA
Screening for Neurotoxity of New Treatment Drugs
Moliver, Mark / Johns Hopkins University
Comments
Be the first to comment on Mark Moliver's grant